Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus

Chest

Volumn 113, Issue 1 SUPPL., 1998, Pages 112S-119S

  Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOGUAZONE; MITOMYCIN; NAVELBINE; PACLITAXEL; VINDESINE;

ADENOCARCINOMA; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; HUMAN; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0031985956     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.1_Supplement.112S     Document Type: Article

References (47)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. Ca Cancer J Clin 1996; 65:5-27
2. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-89
3. Beatty JD, DeBoer G, Rider WD. Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure. Cancer 1979; 43: 2254-67
4. Shao LF, Gao ZG, Yang NP, et al. Results of surgical treatment in 6.123 cases ol carcinoma ol the esophagus and gastric cardia. J Surg Oncol 1989; 42:170-74
5. Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the EORTC. World J Surg 1987; 11:426-36
6. Launois B, Delarue D, Campion JP, et al. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 153:690-92
7. Wang M, Gu XZ, Yin W, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989; 16:325-27
8. Arnott SJ, Duncan W, Kerr GR, et al. Low-dose preoperative radiotherapy for carcinoma of the esophagus: results of a randomized clinical trial. Radiother Oncol 1992; 24:108-13
9. Nygaard K, Hagen S, Hansen HS, et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy: the second Scandinavian trial in esophageal cancer. World J Surg 1992; 16:1104-10
10. Diehl LF. Radiation and chemotherapy in the treatment of esophageal cancer. Gastroenterol Clin North Am 1991; 20: 765-74
11. Teniere P, Hay J-M, Fingerhut A, et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173:123-30
12. Fok M, Sham JST, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective randomized controlled trial. Surgery 1993; 113:138-47
13. Smalley SR, Gunderson LL, Reddy EK, et al. Radiotherapy alone in esophageal carcinoma: current management and future directions of adjuvant, curative, and palliative approaches. Semin Oncol 1994; 21:467-73
14. Jun W, Gao SZ, Gao BZ. Study of radiation dosage in esophageal carcinoma. Chin Med J 1992; 105:132-34
15. Jun W, Gao BZ, Gao SZ. Accelerated hyperfractionation radiotherapy in esophageal cancer: an analysis of 172 cases. Chin Med J 1991; 104:228-29
16. Sischy B, Haller D, Smith T, et al. Interim report of EST 1282 phase II protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus, stage I and II [abstract]. Proc Am Soc Clin Oncol 1990; 9:105
17. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326:1593-98
18. Wittes RE, Adrianza ME, Parsons R, et al. Compilation of phase II results with single antineoplastic agents. Cancer Treat Rep 1985; 4:91-130
19. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995; 322:1004-14
20. Ajani JA, Ilson DH, Daugherty K, et al. Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994; 86:1086-91
21. Conroy T, Etienne PC, Adenis A, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996; 14:164-70
22. Schmoll HJ, Kohne CH, Papageorglou E, et al. Single agent lobaplatin is active in patients with esophageal carcinoma: a phase II evaluation [abstract 483]. Proc Am Soc Clin Oncol 1995; 14:201
23. Ajani JA. Contribution of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994; 21:474-82
24. Ajani JA, Ilson D, Kelsen DP. Taxol in the treatment of patients with upper gastrointestinal carcinomas. Semin Oncol (in press)
25. Fisher B, Gunduz N, Coyle J, et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989; 49:1996-2001
26. Fisher B, Saffer E, Rudock C, et al. Effect of local or systemic treatment prior to primary tumor removal on the production of and response to a serum growth-stimulating factor in mice. Cancer Res 1989; 49:2002-04
27. Schlag P, for the Chirurgische Arbeitsgemeinschaft fur Onkologie der Deutschen Gesellschaft fur Chirurgie Study Group. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992; 127:1146-50
28. Roth JA, Pass HI, Flanagan MM, et al. Randomized clinical trial of preoperative and postoperative chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96:242-48
29. Fok M, Wong J. Prospective randomized study of preoperative chemotherapy in the treatment of resectable esophageal carcinoma. Proceedings of the Fifth World Congress International Society for Diseases of the Esophagus, Kyoto, Japan, 1992; 149
30. Kok T, Tilanus H, Obertop H, et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: an interim report of a randomized controlled trial. Proceedings of the Fifth World Congress International Society for Diseases of the Esophagus, Kyoto, Japan, 1992; 38
31. Anderson LL, Lad TE. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 1982; 50:1587-90
32. Bosch A, Frias Z, Caldwell WL, et al. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol 1979; 18: 103-12
33. Philip PA, Ajani JA. Has combined modality therapy improved outcome of patients with carcinoma of the esophagus? Oncology 1994; 8:37-42
34. Adelstein DJ, Rice TW, Becker M, et al. Concurrent chemotherapy, accelerated fractionation radiation and surgery for esophageal cancer [abstract]. Proc Am Soc Clin Oncol 1996; 15:203
35. Hoffman P, Ferguson M, Haraf D, et al. Neoadjuvant chemotherapy followed by surgery and postoperative chemoradiotherapy for esophageal carcinoma [abstract], Proc Am Soc Clin Oncol 1996; 15:204
36. Shahab N, Wilkes J, Beyer S, et al. Neoadjuvant chemoradiation followed by transhiatal esophagectomy for regional/ locally advanced esophageal carcinoma [abstract]. Proc Am Soc Clin Oncol 1996; 15:209
37. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990; 8:119-27
38. Bates BA, Detterbeck FC, Bernard SA, et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14:156-63
39. Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing transhiatal esophagectomy to preoperative concurrent chemoradiation followed by esophagectomy in locoregional esopohageal carcinoma [abstract]. Proc Am Soc Clin Oncol 1995; 14:199
40. Sileni VC, Tomio L, Koussis H, et al. Concomitant radiotherapy and chemotherapy followed by surgery in esophageal carcinoma with bronchotracheal involvement [abstract]. Proc Am Soc Clin Oncol 1996; 15:199
41. Keane TJ, Harwood AR, Elhakim T, et al. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol 1985; 4:205-10
42. Coia LR, Engstrom PF, Paul A. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987; 5:1783-90
43. Coia LR, Engstrom PF, Paul A, et al. Long-term results of inlusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20:29-36
44. Araujo CM, Souhami L, Gil RA, et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67:2258-61
45. Hatlevoll R, Hagen S, Hansen HS, et al. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus - a prospective randomized multicentre study: the second Scandinavian trial in esophageal cancer. Radiother Oncol 1992; 24:114-16
46. Al-Sarraf M, Martz K, Herskovie A, et al. Superiority of chemoradiotherapy vs radiotherapy in patients with esophageal cancer: final report of an intergroup randomized and confirmed study [abstract 464]. Proc Am Soc Clin Oncol 1996; 15:206
47. Earlam R. An MRC prospective randomized trial of radiotherapy versus surgery for operable squamous cell carcinoma of the esophagus. Ann R Coll Surg Engl 1991; 73:8-12